Home/ Supplements/ Inositol/ Clinical Mood Modulator

Clinical Mood Modulator

product on market Capsule Natural Clinician Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains inositol and St. John's Wort, which have moderate to strong evidence for supporting mood regulation. Mucuna pruriens and lecithin provide additional precursors for neurotransmitter synthesis, though evidence for these specific dosages is more limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Clinical Mood Modulator
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 300.0mg (240 products) 20 studies — no high-quality reviews
Mucuna pruriens
300 mg
Lecithin
100 mg
Vitamin C
60 mg (100% DV)
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
10 mg
Market median: 200.0mg (358 products) 9 studies (A:0, B:2)
2 mg (100% DV)
1.5× RDA — within safe limits 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
70 mcg (100% DV)
1.3× RDA — within safe limits 173 studies (A:0, B:67)

Other Ingredients

All Natural Vegetable Source of
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take 2 capsules daily with 84 oz. of pure water.

Additional Information

PATENT PENDING CLINICAL GRADE FORMULATION

Metadata

Product Details

UPC / SKU0 36733 00804 4
DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormCapsule
DSLD ID18644
Data Updated2026-04-11
Research

Research Evidence

32
Research Sources
50
Avg Quality
19
Rct
7
Meta Analysis
3
Clinical Trial
2
Other
1
Systematic Review
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024 PubMed DOI
B Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Meta Analysis The Journal of clinical endocrinology and metabolism 2024 PubMed DOI
B Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
B Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis
Meta Analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022 PubMed DOI
B Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Meta Analysis Irish journal of medical science 2023 PubMed DOI
B Inositol for subfertile women with polycystic ovary syndrome
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
B Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives
Rct European review for medical and pharmacological sciences 2021 PubMed DOI
B The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Rct European review for medical and pharmacological sciences 2019 PubMed DOI
C Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis
Meta Analysis Expert review of endocrinology & metabolism 2024 PubMed DOI
C Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Rct International journal of food sciences and nutrition PubMed DOI
View all evidence for Inositol →
Compare

Similar Products

View all Inositol products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.